Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. Mai 2026 16:54 ET | Quelle: Refills

Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support

Refills GLP-1 reviewed: compounded semaglutide & tirzepatide, flat pricing, no insurance, clinician review, all 50 states.
10. April 2026 17:13 ET | Quelle: ReadyRx

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

ReadyRx's 2026 update details prescription NAD+ nasal spray and injection access, compounded therapy structure, pricing, and clinician eligibility.
27. Februar 2026 21:02 ET | Quelle: Zealthy

Zealthy ED Platform in 2026 (Including Hardies Sublingual Formulations): Telehealth ED Treatment Options, Compounded Medication Pricing, and What Consumers Should Verify Before Starting

Zealthy ED telehealth platform examined including Hardies compounded sublingual formulations, pricing structure, and consumer verification steps.
14. Oktober 2025 15:30 ET | Quelle: MEDVI

Oral GLP-1 Tablets Gain Momentum as Telehealth Platform MEDVi Expands Access to Compounded Semaglutide and Tirzepatide for Physician-Supervised Weight Management

Los Angeles, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and is not medical advice. Always consult a licensed healthcare professional before...